The effects of lobbying on the FDA’s recall classification
Abstract Background The US Food and Drug Administration (FDA) regulates goods accounting for 20% of US consumers’ total expenditure. The agency’s potential susceptibility to corporate lobbying and political influence may adversely affect the its abilities to fulfill its duties as a vital federal age...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2023-06-01
|
| Serija: | BMC Medical Ethics |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s12910-023-00921-0 |
| Oznake: |
Brez oznak, prvi označite!
|